Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) -tumor barrier (BTB), which limit the efficacy of systemic
therapies. Recent advances in molecular biology
of the potential of immune system-derived miRNAs to revolutionize CVD management and
therapy, addressing a major
the potential of stromal vascular fraction (SVF) cell
therapy as a novel regenerative treatment for ICH. SVF